Sort
40,608 grants matching “prostate cancer”
PSA BASED EARLY DETECTION OF PROSTATE CANCER RECURRENCE
$319,472Jeremy Mg Taylor · University Of Michigan At Ann Arbor · R33 · FY2008 · CA
SOUTHWEST ONCOLOGY GROUP
$319,468Wayne State University · U10 · FY2001 · CA
DEVELOPMENT OF PET RADIOPHARMACEUTICALS TARGETING GRPR
$319,464Buck E Rogers · Washington University · R01 · FY2011 · CA
DEVELOPMENT OF PET RADIOPHARMACEUTICALS TARGETING GRPR
$319,464Buck E Rogers · Washington University · R01 · FY2012 · CA
Prostate Cancer Health Disparity: Role of PDEF
$319,450Hari K. Koul · Lsu Health Sciences Center · R01 · FY2024 · CA
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
$319,441Jane Amanda Skok · New York University School Of Medicine · P01 · FY2022 · CA
Ceramide synthase as a therapy target in prostate cancer
$319,439Adriana Haimovitz-Friedman · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Ceramide synthase as a therapy target in prostate cancer
$319,439Adriana Haimovitz-Friedman · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Ceramide synthase as a therapy target in prostate cancer
$319,439Adriana Haimovitz-Friedman · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Medical Versus Minimally Invasive Therapy for BPH
$319,429Baylor College Of Medicine · U01 · FY2002 · DK
Role of extracellular Hsp90 in epithelial cell polarity and invasion
$319,409Jennifer S Isaacs · Medical University Of South Carolina · R01 · FY2017 · CA
SFSU/UCSF Comprehensive Cancer Partnership Program
$319,399University Of California San Francisco · U56 · FY2002 · CA
Animal Core
$319,394Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2013 · CA
Management of Breathing effects in Radiotherapy Planning
$319,390Thomas R. Bortfeld · Massachusetts General Hospital · R01 · FY2009 · CA
Management of Breathing effects in Radiotherapy Planning
$319,390Thomas R. Bortfeld · Massachusetts General Hospital · R01 · FY2008 · CA
Management of Breathing effects in Radiotherapy Planning
$319,390Thomas R. Bortfeld · Massachusetts General Hospital · R01 · FY2010 · CA
MnTE-2-PyP as a radioprotector in prostate cancer therapy
$319,387Rebecca E Oberley-Deegan · University Of Nebraska Medical Center · R01 · FY2015 · CA
Improved Cryosurgical Destruction of Prostate Cancer
$319,374John C Bischof · University Of Minnesota · R01 · FY2008 · CA
Core 1: Integrated Pathology and Radiology Core (iPRC)
$319,370Wei Huang · University Of Wisconsin-Madison · P50 · FY2023 · CA
Improved Cryosurgical Destruction of Prostate Cancer
$319,370University Of Minnesota Twin Cities · R01 · FY2005 · CA
Control of Prostate-Specific Gene Expression
$319,365Vanderbilt University · R01 · FY2004 · DK
Control of Prostate-Specific Gene Expression
$319,365Vanderbilt University · R01 · FY2003 · DK
Control of Prostate-Specific Gene Expression
$319,365Vanderbilt University · R01 · FY2005 · DK
Genistein-mediated Regulation of Prostate Cancer Cell Motility
$319,357Raymond C Bergan · Northwestern University At Chicago · R01 · FY2009 · CA
LOCALIZATION OF SUSCEPTIBILITY LOCI IN PROSTATE CANCER
$319,346Mayo Clinic · R01 · FY2004 · CA